Trial intelligence / Profile preview

Chymotrypsin injection, serratiopeptidase, and oral corticosteroids to reduce postoperative complications after impacted lower third molar surgery

TCTR20200828006Phase 4Completed

Sponsor
Faculty of Dentistry, University of Technology
Start
Aug 2014
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of chymotrypsin, serrapeptase, corticosteroids in postoperative pain, trismus, sponsored by Faculty of Dentistry, University of Technology. Started Aug 2014; status: completed.

02

Drugs

chymotrypsinserrapeptasecorticosteroids
03

Conditions

postoperative paintrismus

Beyond the preview

Go deeper on TCTR20200828006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200828006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call